Sat Jul 4 04:13:34 SGT 2015  
    STD (Sexually Transmitted Disease), South Africa
HIV PEP (post-exposure prophylaxis): Stop HIV infection within 3 days after unprotected sex.
HIV test: 20 minute rapid test to accurately detect HIV infection 28 days after unprotected sex.
STD testing: Full & comprehensive sexually transmitted disease testing.

STD (Sexually Transmitted Disease), South Africa


STD (Sexually Transmitted Disease), South Africa @std_info: STD (Sexually Transmitted Disease) symptoms in men/women, screening/diagnosis, testing/check and treatment, South Africa - Private and confidential service.

Keywords: STD (Sexually Transmitted Disease) South Africa, South Africa STD (Sexually Transmitted Disease), STD (Sexually Transmitted Disease).


Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: STD (Sexually Transmitted Disease), South Africa
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

Budget airlines based in Singapore:

Budget airlines operating in Singapore:

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception (females only)
HIV PrEP (pre-exposure prophylaxis) STD vaccine:
- Hepatitis vaccine
- HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV prevention
HIV PEP (post-exposure prophylaxis) treatment
- Stop HIV infection after exposure.
STD testing.
If STD symptoms appear, then do STD treatment.
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.
Emergency contraception (females only)
2 weeks HIV DNA PCR test
1 month 20 minute HIV rapid test - SD Bioline HIV Ag/Ab Combo:
- Fingerprick blood sampling.
3 months 20 minute HIV rapid test - OraQuick®:
- Oral saliva or
- Fingerprick blood sampling.
Full & comprehensive STD testing
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.

Location reference

Latest News

ECDC guidance on prevention of HIV and STIs suggests seven components for inclusion in national EU/EEA public health programmes.
Fri, 03 Jul 2015 12:36:02 +0100 | Euro Surveill

Applying the RE-AIM Framework to Evaluate the Dissemination and Implementation of Clinical Practice Guidelines for Sexually Transmitted Infections.
Fri, 03 Jul 2015 12:22:41 +0100 | Journal of Korean Medical Science
This study evaluated the dissemination and implementation of the Sexually Transmitted Infections-Korean Guidelines (STIKG) by applying the reach, effectiveness, adoption, implementation and maintenance (RE-AIM) framework. A survey questionnaire was administered to clinicians via the internet. Among the 332 respondents, 190 (57.2%) stated that they were aware of STIKG and 107 (33.2%) implemented STIKG in their practice. The odds that a physician was exposed to STIKG (dissemination) were 2.61 times greater among physicians with previous training or education for any CPG than those who did not. Clinicians who indicated that STIKG were easy to understand were 4.88 times more likely to implement STIKG in their practice than those who found them not so easy. When a clinician's workplace had a su...

The Male Factor: Human Papillomavirus (HPV) and HPV4 Vaccine Acceptance Among African American Young Men
Fri, 03 Jul 2015 08:31:48 +0100 | Journal of Community Health
This study was part of a larger project of HPV4 vaccine acceptance. Participants completed a 68-item questionnaire about personal characteristics, HPV, and the HPV4 vaccine. A majority of the young men had heard about HPV (85 %, n = 58), however, only 38 % (n = 26) new about the HPV4 vaccine for women. Only 12.2 % (n = 9) of the respondents knew of an HPV4 vaccine for men. The top three barriers to HPV4 vaccination were that insurance would not cover the vaccine; they would have to pay a lot for the vaccine and worrying that the vaccine is not safe. Study findings suggest that HPV and HPV4 education programs, and low or no cost HPV4 vaccinations for African American young men are needed. (Source: Journal of Community Health)

Alcohol use and unintended sexual consequences among women attending an urban sexually transmitted infections clinic - Lewis D, Hutton HE, Agee TA, McCaul ME, Chander G.
Fri, 03 Jul 2015 08:30:20 +0100 | SafetyLit: All (Unduplicated)
BACKGROUND: Although alcohol use has been linked with a variety of sexual behaviors, we lack an understanding of what precise events occur when women drink that may lead to emotional or physical harms. METHODS: To fill this gap, we qualitatively ex... (Source: SafetyLit: All (Unduplicated))

Re-examining the effectiveness of monogamy as an STI-preventive strategy
Fri, 03 Jul 2015 00:00:00 +0100 | Preventive Medicine
Publication date: September 2015 Source:Preventive Medicine, Volume 78 Author(s): Terri D. Conley , Jes L. Matsick , Amy C. Moors , Ali Ziegler , Jennifer D. Rubin The utility of monogamy (in practice) as a strategy for preventing sexually transmitted infections (STIs) was investigated. By reviewing recent literature surrounding monogamous relationships and sexual behaviors, the authors determined that monogamy might not prevent against STIs as expected. First, the authors elucidate the ways in which public health officials and the general public define and interpret monogamy and discuss how this contributes to monogamy as an ineffectual STI prevention strategy. Second, the authors provide evidence that individuals' compliance with monogamy is likely to be low, similar to rates of compli...

Detecting re-infection in patients after an initial diagnosis of gonorrhoea: is routine recall for re-screening useful?
Thu, 02 Jul 2015 00:00:00 +0100 | International Journal of STD and AIDS
To assess the outcome of routine sexually transmitted infection re-screening after a three-month interval in unselected patients diagnosed with gonorrhoea, we sought to assess whether this active approach would result in an increase in the number of people attending clinic and subsequently diagnosed with gonorrhoea re-infection, compared with normal re-presentation rates. A recall group of patients were invited for re-screening three months after their initial diagnosis of gonorrhoea. Permission was sought to send a reminder two weeks prior to their scheduled recall appointment. Comparisons were made with a historical control group of patients with gonorrhoea in the absence of any formal recall. Of the 242 patients in the intervention arm, 96 (40%) re-attended within six months, and 15 (6%...

Self-administered sample collection for screening of sexually transmitted infection among reservation-based American Indian youth
Thu, 02 Jul 2015 00:00:00 +0100 | International Journal of STD and AIDS
American Indians suffer a disproportionate burden of sexually transmitted infection, particularly adolescents. Screening access barriers in rural and reservation-based communities necessitate alternatives to clinic-based options. Self-administered screening for three sexually transmitted infections was piloted among 32 American Indian adolescents aged 18 to 19. Participants self-collected in a private location; specimens were processed by trained, American Indian paraprofessionals and analysis was conducted by an outside laboratory. Participants testing positive were treated by a Public Health Nurse from the Indian Health Service. Results suggest high overall acceptability: 69% preferred a self-administered method over clinic-based screening, 75% would encourage their friends to use this m...

Successful treatment of refractory Trichomonas vaginalis infection using intravenous metronidazole
Thu, 02 Jul 2015 00:00:00 +0100 | International Journal of STD and AIDS
Trichomonas vaginalis is a sexually transmitted protozoan infection resulting in a vulvo-vaginitis and altered vaginal discharge in symptomatic women. Since its introduction in the 1960 s, metronidazole has been the first-line drug for trichomonal infection. Other nitroimidazoles, such as tinidazole, are used as alternative regimens with similar activity but at a greater expense. Treatment failure usually represents patient non-compliance or reinfection, although metronidazole resistance has previously been documented. Sensitivity testing is currently not available in the UK. Patients with disease unresponsive to first-line treatments pose a major challenge, as therapeutic options are limited. This case looks at a patient with refractory disease over an 18-month period, where intravenous i...

Primary syphilis of the oropharynx: an unusual location of a chancre
Thu, 02 Jul 2015 00:00:00 +0100 | International Journal of STD and AIDS
A 33-year-old man presented with a two-week history of an asymptomatic ulcer of the oropharynx and submandibular lymph nodes swelling. Laboratory examinations were normal, but serological tests revealed positivity for rapid plasma reagin, Treponema pallidum haemagglutination assay and anti-T. pallidum IgM antibodies. Since the patient denied any homosexual relationship, a biopsy of the lesion was performed, which confirmed primary syphilis. The patient received an intramuscular injection of Benzathine Penicillin G (2.4 MU) with complete resolution of the lesion. Extragenital chancres occur in at least 5% of patients with primary syphilis, and the oral mucosa is the most frequent location as a consequence of orogenital/oroanal contact with an infectious lesion. Because of their transient na...

Sexual Activity and Condom Use among Israeli Adolescents
Thu, 02 Jul 2015 00:00:00 +0100 | The Journal of Sexual Medicine
ConclusionsHealth educators should consider the barriers cited by adolescents and the deterrent techniques they recommend when planning interventions to encourage condom use. Shilo G and Mor Z. Sexual activity and condom use among Israeli adolescents. J Sex Med **;**:**–**. (Source: The Journal of Sexual Medicine)